TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32291222

Group type: EXPERIMENTAL
Intervention: Group education, splinting, and nerve and tendon gliding exercises (n = 52)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Waitlist without additional care (n = 53)
Number of subjects: 105
Study: 35473471

Group type: EXPERIMENTAL
Intervention: 10-week baby swimming intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study: 35862782

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg intragastric administration)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (no simvastatin treatment)
Number of subjects: 58
Study: 34423361

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730

Group type: EXPERIMENTAL
Intervention: NT-proBNP and hs-cTnT
Number of subjects: 3730

Group type: EXPERIMENTAL
Intervention: Primary outcome risk score
Number of subjects: 3730

Group type: EXPERIMENTAL
Intervention: Mortality risk model
Number of subjects: 3730
Study: 33674231

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Intensive medical therapy (Med)
Number of subjects: 69
Study: 34154906

Group type: EXPERIMENTAL
Intervention: Professional continuous glucose monitoring (CGM)
Number of subjects: 100
Study: 33031018

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR) - 70 mL (∼5 mmol nitrate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PL) - 70 mL (∼0.003 mmol nitrate)
Number of subjects: 8
Study: 35500015

Group type: EXPERIMENTAL
Intervention: READY (Acceptance and Commitment Therapy-based group resilience-training program)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Group relaxation program (control)
Number of subjects: 240
Study: 33875528

Group type: EXPERIMENTAL
Intervention: Training group utilizing photography
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no photographs or feedback)
Number of subjects: 50
Study: 34325134

Group type: EXPERIMENTAL
Intervention: High-efficiency particulate air filter air purifier
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo air purifier
Number of subjects: 24
Study: 32277134

Group type: EXPERIMENTAL
Intervention: Single-session RFA (group 1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Two-session RFA (group 2)
Number of subjects: 56
Study: 35307538

Group type: EXPERIMENTAL
Intervention: Family-focused therapy with medication management as needed
Number of subjects: 114

Group type: COMPARATOR
Intervention: Enhanced care psychoeducation with medication management as needed
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Both interventions (Family-focused therapy and Enhanced care psychoeducation)
Number of subjects: 114
Study: 32341190

Group type: EXPERIMENTAL
Intervention: Prognostic scenario of severe functional disability (SD)
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: Prognostic scenario of remaining in a vegetative state (VS)
Number of subjects: 1588
Study: 34952870

Group type: EXPERIMENTAL
Intervention: Shared care with mental health professionals in GP offices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care without shared mental health professionals)
Number of subjects: 0
Study: 32909467

Group type: EXPERIMENTAL
Intervention: High Intensity Exercise with Self-Regulatory BCTs
Number of subjects: 577

Group type: COMPARATOR
Intervention: High Intensity Exercise without Self-Regulatory BCTs
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Low-to-Moderate Intensity Exercise with Self-Regulatory BCTs
Number of subjects: 577

Group type: COMPARATOR
Intervention: Low-to-Moderate Intensity Exercise without Self-Regulatory BCTs
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Self-Regulatory BCTs
Number of subjects: 577

Group type: COMPARATOR
Intervention: No Self-Regulatory BCTs
Number of subjects: 577
Study: 34129239

Group type: EXPERIMENTAL
Intervention: Antithrombotic therapies (ATT)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Monotherapy (Low-dose aspirin)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Warfarin monotherapy
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: DAPT (Aspirin/Clopidogrel)
Number of subjects: 329
Study: 34660630

Group type: EXPERIMENTAL
Intervention: Training group (supervised training program)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 34132792

Group type: EXPERIMENTAL
Intervention: Student-centric algorithm
Number of subjects: 50000

Group type: COMPARATOR
Intervention: Program-centric algorithm
Number of subjects: 50000
Study: 32990607

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate and high-fiber diet and education
Number of subjects: 44

Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 44
Study: 35448942

Group type: EXPERIMENTAL
Intervention: IV HBB 20 mg in 1 ml (Hyoscine group)
Number of subjects: 160

Group type: COMPARATOR
Intervention: 0.9% saline (Control group)
Number of subjects: 160
Study: 33169175

Group type: EXPERIMENTAL
Intervention: Short stems
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard-length stems
Number of subjects: 29
Study: 35341991

Group type: EXPERIMENTAL
Intervention: TEAM intervention (group-based behavioral intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual T1D care
Number of subjects: 0
Study: 33338505

Group type: EXPERIMENTAL
Intervention: Choice (self-sampling at home for HPV testing)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Standard of care screening at the local health department (SCS)
Number of subjects: 335
Study: 32685258

Group type: EXPERIMENTAL
Intervention: tranexamic acid (10 mg/kg)
Number of subjects: 69

Group type: COMPARATOR
Intervention: normal saline (placebo)
Number of subjects: 69
Study: 36309673

Group type: EXPERIMENTAL
Intervention: Telephone-based postnatal care (midwife-led telephone counselling within 48 hours post-discharge plus telephone access to midwife during postnatal period)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual postnatal care
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Telephone-based postnatal care
Number of subjects: 400
Study: 33827781

Group type: EXPERIMENTAL
Intervention: Stenting (CAS) or endarterectomy (CEA) in recent trials
Number of subjects: 5001

Group type: COMPARATOR
Intervention: Medical therapy in earlier trials
Number of subjects: 5001
Study: 35565662

Group type: EXPERIMENTAL
Intervention: Lactobacillus gasseri CP2305
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32219594

Group type: EXPERIMENTAL
Intervention: M1 anodal transcranial direct current stimulation (a-tDCS) with SRTT
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham a-tDCS with SRTT
Number of subjects: 39

Group type: COMPARATOR
Intervention: SRTT-only control
Number of subjects: 39
Study: 33152119

Group type: EXPERIMENTAL
Intervention: STAT3 activation (evidence of activation determined by immunohistochemical analysis of STAT3 phosphorylation)
Number of subjects: 5694

Group type: COMPARATOR
Intervention: No STAT3 activation
Number of subjects: 5694
Study: 33301541

Group type: EXPERIMENTAL
Intervention: Digital Inclinometer (DI)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Inertial Motion Capture (IMC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Tape Measure (TM)
Number of subjects: 22
Study: 35422208

Group type: EXPERIMENTAL
Intervention: Regional Anesthesia (RA) with Dexmedetomidine (DEX: 1 μg/kg infused over 10 min followed by 0.5 μg/kg/h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: General Anesthesia (GA) with Dexmedetomidine (DEX: 0.1 μg/kg/min over 10 min followed by 0.4‐0.7 μg/kg/h)
Number of subjects: 50
Study: 33038782

Group type: EXPERIMENTAL
Intervention: Chamomile extract nasal drop
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 35762612

Group type: EXPERIMENTAL
Intervention: Prophylactic retrorectus mesh reinforcement (mesh group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Primary closure of midline laparotomy (no-mesh group)
Number of subjects: 120
Study: 33638248

Group type: EXPERIMENTAL
Intervention: Group Education Program (GEP)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: WhatsApp Education Program (WEP)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 253
Study: 616782735

Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise and resistance training for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Resistance training for 3 months (Control)
Number of subjects: 100
Study: 32266395

Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informal caregivers
Number of subjects: 0
Study: 32594135

Group type: EXPERIMENTAL
Intervention: prednisolone (10 mg daily) plus 5α-reductase inhibitor (finasteride 5 mg daily or dutasteride 0.5 mg daily)
Number of subjects: 19

Group type: COMPARATOR
Intervention: prednisolone (10 mg daily)
Number of subjects: 19
Study: 34320250

Group type: EXPERIMENTAL
Intervention: 300 mg PTAH daily for 1.5 years (Group A)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: 300 mg PTAH daily for 2 years (Group B)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: PTAH treatment
Number of subjects: 142
Study: 33441203

Group type: EXPERIMENTAL
Intervention: Intervention group (school-based obesity intervention)
Number of subjects: 5926

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 5926
Study: 36167118

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) with a fixed stimulation current of 200 mA and pulse frequency of 20 Hz
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) with higher currents (100-250 mA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Eccentric muscle contractions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Familiarization session of electrical stimulation (ES)
Number of subjects: 8
Study: 35947398

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 1944

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 1944
Study: 36120087

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 3350 17g once daily for 24 weeks
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study: 33933090

Group type: EXPERIMENTAL
Intervention: Digital thermography imaging
Number of subjects: 50
Study: 33374465

Group type: EXPERIMENTAL
Intervention: PAP of maximal conditioning contractions (PAP MCC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: PAP of maximal strength contractions (PAP MSC)
Number of subjects: 7
Study: 35177180

Group type: EXPERIMENTAL
Intervention: Budesonide combined with pulmonary surfactant (PS) at a dose of 0.25 mg/kg for intratracheal instillation with PS application.
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional treatment with pulmonary surfactant (PS) alone at an initial dose of 200 mg/kg, followed by 100 mg/kg according to the condition.
Number of subjects: 122
Study: 34258275

Group type: EXPERIMENTAL
Intervention: Integrated intervention based on protection motivation theory and implementation intention
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study: 36056473

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33098992

Group type: COMPARATOR
Intervention: Carboplatin (C)
Number of subjects: 135
Study: 35322019

Group type: EXPERIMENTAL
Intervention: Overweight BMI group (28 kg/m2)
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Underweight BMI group
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Obesity group
Number of subjects: 773

Group type: COMPARATOR
Intervention: Normal weight group
Number of subjects: 773
Study: 32151211

Group type: EXPERIMENTAL
Intervention: 4 mg of intravenous zoledronate
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplements
Number of subjects: 1
Study: 35608106

Group type: EXPERIMENTAL
Intervention: Oral infigratinib 125 mg daily on days 1-21 of a 28-day cycle for up to 52 weeks
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 33617696

Group type: EXPERIMENTAL
Intervention: Direct-access physiotherapy (PT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual care by emergency physician
Number of subjects: 78
Study: 37332625

Group type: EXPERIMENTAL
Intervention: Early literacy promotion (board books and reading promotion beginning with newborns)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard literacy promotion (beginning at 6 months, only weekly text messages on safety)
Number of subjects: 120
Study: 36400394

Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (intervention group)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (control group)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Postoperative questionnaires including preoperative answers (intervention group) for cervical spine patients
Number of subjects: 236

Group type: COMPARATOR
Intervention: Postoperative questionnaires without preoperative answers (control group) for cervical spine patients
Number of subjects: 236
Study: 33836985

Group type: EXPERIMENTAL
Intervention: Peer social support group intervention using the CARES skills framework
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (second year students)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Peer social support group intervention
Number of subjects: 78
Study: 32787953

Group type: EXPERIMENTAL
Intervention: Patient Note Scoring rubric (PNS)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Clinical Reasoning Task (CRT)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Clinical Data Interpretation (CDI)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Summary Statement Assessment Rubric (SSAR)
Number of subjects: 235
Study: 35080051

Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 220

Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 220
Study: 33398890

Group type: EXPERIMENTAL
Intervention: Mefloquine (2 doses taken as a split dose with a meal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sulfadoxine–pyrimethamine (4 doses)
Number of subjects: 0
Study: 35329896

Group type: EXPERIMENTAL
Intervention: Exergame intervention (20 minutes, twice per week)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (regular physical education classes only)
Number of subjects: 58
Study: 32499254

Group type: EXPERIMENTAL
Intervention: Usual care plus KOMPACT (2 hours 20 minutes of preoperative physiotherapy informed by Acceptance and Commitment Therapy)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual care (education class)
Number of subjects: 51
Study: 32603873

Group type: EXPERIMENTAL
Intervention: Pain Concepts Questionnaire (PCQ)
Number of subjects: 0
Study: 33070288

Group type: EXPERIMENTAL
Intervention: Alpelisib 300 mg in fasted state
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpelisib in fed state
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranitidine in fasted state
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pivotal clinical formulation (PCF) and commercial formulation (CF)
Number of subjects: 0
Study: 33571645

Group type: EXPERIMENTAL
Intervention: Cone-beam computed tomography scans
Number of subjects: 100
Study: 32921505

Group type: EXPERIMENTAL
Intervention: Patient Concerns Inventory (PCI)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Non-PCI
Number of subjects: 288
Study: 36271804

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32857331

Group type: EXPERIMENTAL
Intervention: 7 days antibiotics
Number of subjects: 96

Group type: COMPARATOR
Intervention: 10 days antibiotics
Number of subjects: 96
Study: 32427125

Group type: EXPERIMENTAL
Intervention: Kapalbhathi pranayama (5 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal breathing (control group)
Number of subjects: 50
Study: 34605713

Group type: EXPERIMENTAL
Intervention: Report cards featuring salient information about donor organ utilization rates
Number of subjects: 2038

Group type: EXPERIMENTAL
Intervention: Report cards featuring overall survival rates
Number of subjects: 2038

Group type: COMPARATOR
Intervention: Conservative donor acceptance strategy
Number of subjects: 2038
Study: 33903925

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA)
Number of subjects: 0
Study: 35694051

Group type: EXPERIMENTAL
Intervention: Tele-guided imagery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 33274215

Group type: EXPERIMENTAL
Intervention: Ovarian preservation
Number of subjects: 281

Group type: COMPARATOR
Intervention: Nonovarian preservation
Number of subjects: 281
Study: 35556238

Group type: EXPERIMENTAL
Intervention: Connective Tissue Manipulation (CTM)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo Therapeutic Ultrasound (US)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 33658407

Group type: EXPERIMENTAL
Intervention: Enamel‐sealing liquid (Tiefenfluorid)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: FluoroLux
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: InnoDent
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ClinproTM XT Varnish
Number of subjects: 36
Study: 616473919

Group type: EXPERIMENTAL
Intervention: Eccentric training for plantar flexors performed using an isokinetic dynamometer, 3 times a week for 8 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 24
Study: 36129266

Group type: EXPERIMENTAL
Intervention: Preeclamptic pregnant women (Group 1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preeclamptic pregnant women (Group 3)
Number of subjects: 150
Study: 34151493

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine (3 mg/kg/day) for 4 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral dexamethasone mini pulse (2.5 mg dexamethasone on two consecutive days/week for 4 months)
Number of subjects: 50
Study: 32700655

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg oral daily (group RXE)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Enoxaparin 40 IU/day subcutaneously for 14 days (group ENO)
Number of subjects: 160
Study: 36070255

Group type: EXPERIMENTAL
Intervention: Spending money on someone else
Number of subjects: 133

Group type: COMPARATOR
Intervention: Spending money on oneself
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Direct measure of happiness when spending money on someone else
Number of subjects: 133
Study: 34302514

Group type: EXPERIMENTAL
Intervention: 8% capsaicin treatment
Number of subjects: 18
Study: 32673877

Group type: EXPERIMENTAL
Intervention: Patient Advocate (PA) intervention for 6 months
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 312
Study: 32772049

Group type: EXPERIMENTAL
Intervention: Personalized medicine based on human genetics for cardiovascular diseases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies examining loss-of-function genetic variations
Number of subjects: 0
Study: 32270774

Group type: EXPERIMENTAL
Intervention: 1-day low residue diet (LRD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2-day low residue diet (LRD)
Number of subjects: 0
Study: 34724045

Group type: EXPERIMENTAL
Intervention: Colloid administration
Number of subjects: 973

Group type: COMPARATOR
Intervention: Crystalloid administration
Number of subjects: 973
Study: 33254172

Group type: EXPERIMENTAL
Intervention: Asleep deep brain stimulation (DBS) under general anesthesia without microelectrode recordings (MER) (20 patients)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Awake deep brain stimulation (DBS) under local anesthesia with MER (9 patients)
Number of subjects: 29
Study: 35521789

Group type: EXPERIMENTAL
Intervention: Glucagon (1 mg s.c. injection)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Copeptin cut-off level of 4.6 pmol/L
Number of subjects: 42
Study: 32125619

Group type: EXPERIMENTAL
Intervention: Acupuncture with deqi
Number of subjects: 70

Group type: COMPARATOR
Intervention: Acupuncture without deqi
Number of subjects: 70
Study: 34727808

Group type: EXPERIMENTAL
Intervention: Community capacity‐building intervention
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 241
Study: 34927195

Group type: EXPERIMENTAL
Intervention: n‐3 LCPUFA supplementation
Number of subjects: 736
Study: 33150384

Group type: COMPARATOR
Intervention: Rurioctocog alfa pegol prophylaxis targeting FVIII troughs of 1% to 3% (reference arm)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Rurioctocog alfa pegol prophylaxis targeting FVIII troughs of 8% to 12% (elevated arm)
Number of subjects: 115
Study: 32633196

Group type: EXPERIMENTAL
Intervention: Postradiation swallowing evaluation
Number of subjects: 168
Study: 35595747

Group type: EXPERIMENTAL
Intervention: 7-day standardized Mediterranean diet (MedDiet)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control diet inspired by Canadian macronutrient intake (CanDiet)
Number of subjects: 7
Study: 33189891

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir
Number of subjects: 0
Study: 32507136

Group type: EXPERIMENTAL
Intervention: Russian current group (RCG)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study: 33307546

Group type: EXPERIMENTAL
Intervention: GenOMICC genome-wide association study
Number of subjects: 2244

Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 2244

Group type: EXPERIMENTAL
Intervention: Transcriptome-wide association in lung tissue
Number of subjects: 2244
Study: 32424022

Group type: EXPERIMENTAL
Intervention: Less-processed whole grains
Number of subjects: 31

Group type: COMPARATOR
Intervention: Finely milled grains
Number of subjects: 31
Study: 36308110

Group type: EXPERIMENTAL
Intervention: Intracameral lidocaine hydrochloride 1% and tropicamide injection 0.02%
Number of subjects: 32